TreeWAS – Variant ID: rs4746003

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Y40.0 Penicillins	0.197	0.803	0.000
Y40 Systemic antibiotics	0.195	0.805	0.000
Y40.8 Other systemic antibiotics	0.192	0.808	0.000
Y40.5 Aminoglycosides	0.172	0.828	0.000
Y40.3 Macrolides	0.171	0.829	0.000
Y40.9 Systemic antibiotic, unspecified	0.155	0.845	0.000
Y40.4 Tetracyclines	0.140	0.860	0.000
Y40.2 Chloramphenicol group	0.140	0.860	0.000
Y40.6 Rifamycins	0.140	0.860	0.000
Y40.7 Antifungal antibiotics, systemically used	0.137	0.863	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.126	0.874	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.029	0.971	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.026	0.974	0.000
M06.9 Rheumatoid arthritis, unspecified	0.025	0.975	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.024	0.976	0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.024	0.976	0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.023	0.976	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.023	0.977	0.000
Y48 Anaesthetics and therapeutic gases	0.023	0.977	0.000
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.023	0.977	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.022	0.978	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.022	0.978	0.000
Y48.2 Other and unspecified general anaesthetics	0.022	0.978	0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.021	0.979	0.000
M06.98 Rheumatoid arthritis, unspecified (Other)	0.021	0.979	0.000
Y49.5 Other antipsychotics and neuroleptics	0.021	0.979	0.000
Y54.5 Other diuretics	0.021	0.979	0.000
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.021	0.979	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.020	0.979	0.000
Y59 Other and unspecified vaccines and biological substances	0.020	0.980	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.020	0.980	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.020	0.980	0.000
Y58 Bacterial vaccines	0.019	0.981	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.019	0.981	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.019	0.981	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.019	0.981	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.018	0.982	0.000
Y46.2 Hydantoin derivatives	0.018	0.982	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.018	0.982	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.017	0.982	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.017	0.982	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.017	0.982	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.017	0.982	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.017	0.982	0.000
Y51.0 Anticholinesterase agents	0.017	0.982	0.000
Y46.6 Other and unspecified antiepileptics	0.017	0.983	0.000
Y49.9 Psychotropic drug, unspecified	0.017	0.983	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.017	0.983	0.000
Y49.7 Psychostimulants with abuse potential	0.017	0.983	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.017	0.983	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.017	0.983	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.017	0.983	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.017	0.983	0.000
Y54.8 Agents affecting uric acid metabolism	0.017	0.983	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.017	0.983	0.000
Y48.5 Therapeutic gases	0.017	0.983	0.000
Y48.1 Parenteral anaesthetics	0.017	0.983	0.000
Y48.0 Inhaled anaesthetics	0.017	0.983	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.017	0.983	0.000
Y48.3 Local anaesthetics	0.017	0.983	0.000
Y46.7 Anti-Parkinsonism drugs	0.017	0.983	0.000
Y49.2 Other and unspecified antidepressants	0.017	0.983	0.000
Y46.4 Iminostilbenes	0.017	0.983	0.000
Y59.3 Immunoglobulin	0.016	0.984	0.000
Y46.8 Antispasticity drugs	0.016	0.984	0.000
Y46.5 Valproic acid	0.016	0.984	0.000
Y46.3 Deoxybarbiturates	0.016	0.984	0.000
Y46.1 Oxazolidinediones	0.016	0.984	0.000
Y46.0 Succinimides	0.016	0.984	0.000
Y54.4 Loop [high-ceiling] diuretics	0.016	0.984	0.000
Y54.9 Mineral salts, not elsewhere classified	0.016	0.984	0.000
Y54.7 Agents affecting calcification	0.016	0.984	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.016	0.984	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.016	0.984	0.000
Y54.0 Mineralocorticoids	0.016	0.984	0.000
Y41.0 Sulphonamides	0.016	0.984	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.016	0.984	0.000
Y48.4 Anaesthetic, unspecified	0.015	0.985	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.015	0.985	0.000
Y59.9 Vaccine or biological substance, unspecified	0.015	0.985	0.000
Y59.8 Other specified vaccines and biological substances	0.015	0.985	0.000
Y59.2 Protozoal vaccines	0.015	0.985	0.000
Y59.1 Rickettsial vaccines	0.015	0.985	0.000
Y59.0 Viral vaccines	0.015	0.985	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.014	0.986	0.000
Y55.5 Anticommon cold drugs	0.014	0.986	0.000
Y55.4 Expectorants	0.014	0.986	0.000
Y55.3 Antitussives	0.014	0.986	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.014	0.986	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.014	0.986	0.000
Y55.0 Oxytocic drugs	0.014	0.986	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.014	0.986	0.000
Y58.0 BCG vaccine	0.014	0.986	0.000
Y58.9 Other and unspecified bacterial vaccines	0.014	0.986	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.014	0.986	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.014	0.986	0.000
Y58.5 Diphtheria vaccine	0.014	0.986	0.000
Y58.4 Tetanus vaccine	0.014	0.986	0.000
Y58.3 Plague vaccine	0.014	0.986	0.000
Y58.2 Cholera vaccine	0.014	0.986	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.014	0.986	0.000
Y50.9 Central nervous system stimulant, unspecified	0.014	0.986	0.000
Y50.8 Other central nervous system stimulants	0.014	0.986	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.014	0.986	0.000
Y50.1 Opioid receptor antagonists	0.014	0.986	0.000
Y50.0 Analeptics	0.014	0.986	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.013	0.986	0.000
Y41.1 Antimycobacterial drugs	0.013	0.986	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.013	0.987	0.000
Y41.5 Antiviral drugs	0.013	0.987	0.000
Y41.4 Anthelminthics	0.013	0.987	0.000
Y41.3 Other antiprotozoal drugs	0.013	0.987	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.013	0.987	0.000
Y42.9 Other and unspecified hormone antagonists	0.013	0.987	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.013	0.987	0.000
Y42.7 Androgens and anabolic congeners	0.013	0.987	0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.012	0.987	0.000
Y56.9 Topical agent, unspecified	0.012	0.988	0.000
Y56.8 Other topical agents	0.012	0.988	0.000
Y56.7 Dental drugs, topically applied	0.012	0.988	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.012	0.988	0.000
Y56.5 Ophthalmological drugs and preparations	0.012	0.988	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.012	0.988	0.000
Y56.3 Emollients, demulcents and protectants	0.012	0.988	0.000
Y56.2 Local astringents and local detergents	0.012	0.988	0.000
Y56.1 Antipruritics	0.012	0.988	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.012	0.988	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.012	0.988	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.012	0.988	0.000
Y47.4 Bromine compounds	0.012	0.988	0.000
Y47.3 Paraldehyde	0.012	0.988	0.000
Y47.2 Chloral derivatives	0.012	0.988	0.000
Y47.0 Barbiturates, not elsewhere classified	0.012	0.988	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.012	0.988	0.000
Y42.1 Thyroid hormones and substitutes	0.011	0.988	0.000
Y54.3 Benzothiadiazine derivatives	0.011	0.988	0.000
Y44 Agents primarily affecting blood constituents	0.011	0.988	0.000
F31.0 Bipolar affective disorder, current episode hypomanic	0.012	0.988	0.000
Y42.4 Oral contraceptives	0.011	0.988	0.000
Y42.2 Antithyroid drugs	0.011	0.988	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.011	0.989	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.010	0.989	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.010	0.989	0.000
Y53.7 Emetics	0.010	0.989	0.000
Y53.6 Antidiarrhoeal drugs	0.010	0.989	0.000
Y53.5 Digestants	0.010	0.989	0.000
Y53.3 Saline and osmotic laxatives	0.010	0.989	0.000
Y53.2 Stimulant laxatives	0.010	0.989	0.000
Y53.0 Histamine H2-receptor antagonists	0.010	0.989	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.010	0.990	0.000
F31 Bipolar affective disorder	0.010	0.990	0.000
Y47.1 Benzodiazepines	0.010	0.990	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.010	0.990	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.010	0.990	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.009	0.991	0.000
Y53.4 Other laxatives	0.009	0.991	0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.009	0.991	0.000
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.009	0.991	0.000
Y45.1 Salicylates	0.009	0.991	0.000
Y45.5 4-Aminophenol derivatives	0.009	0.991	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.009	0.991	0.000
Y45.4 Antirheumatics	0.009	0.991	0.000
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.009	0.991	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.008	0.991	0.000
Y44.7 Plasma substitutes	0.008	0.991	0.000
Y44.6 Natural blood and blood products	0.008	0.991	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.008	0.991	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.008	0.991	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.008	0.991	0.000
Y57 Other and unspecified drugs and medicaments	0.008	0.991	0.000
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.008	0.991	0.000
Y44.5 Thrombolytic drugs	0.008	0.992	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.008	0.992	0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.008	0.992	0.000
F31.7 Bipolar affective disorder, currently in remission	0.008	0.992	0.000
Y43 Primarily systemic agents	0.008	0.992	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.008	0.992	0.000
F31.6 Bipolar affective disorder, current episode mixed	0.008	0.992	0.000
Y45.0 Opioids and related analgesics	0.008	0.992	0.000
F31.8 Other bipolar affective disorders	0.007	0.993	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.007	0.993	0.000
C64 Malignant neoplasm of kidney, except renal pelvis	0.000	0.993	0.007
E14.3 With ophthalmic complications	0.007	0.993	0.000
G31.9 Degenerative disease of nervous system, unspecified	0.000	0.994	0.006
Y57.7 Vitamins, not elsewhere classified	0.006	0.994	0.000
Y57.4 Pharmaceutical excipients	0.006	0.994	0.000
Y57.3 Alcohol deterrents	0.006	0.994	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.006	0.994	0.000
Y57.1 Lipotropic drugs	0.006	0.994	0.000
Y57.0 Appetite depressants [anorectics]	0.006	0.994	0.000
Y43.0 Antiallergic and antiemetic drugs	0.006	0.994	0.000
Y43.9 Primarily systemic agent, unspecified	0.006	0.994	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.006	0.994	0.000
Y43.6 Enzymes, not elsewhere classified	0.006	0.994	0.000
Y43.5 Acidifying and alkalising agents	0.006	0.994	0.000
Y43.2 Antineoplastic natural products	0.006	0.994	0.000
Y57.6 Other diagnostic agents	0.006	0.994	0.000
Y43.4 Immunosuppressive agents	0.006	0.994	0.000
G31.8 Other specified degenerative diseases of nervous system	0.000	0.994	0.006
F31.9 Bipolar affective disorder, unspecified	0.006	0.994	0.000
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.000	0.994	0.006
Y45.2 Propionic acid derivatives	0.005	0.994	0.000
S82.40 Fracture of fibula alone (closed)	0.006	0.994	0.000
Y45.8 Other analgesics and antipyretics	0.005	0.994	0.000
C92.0 Acute myeloid leukaemia	0.000	0.995	0.005
G31.0 Circumscribed brain atrophy	0.000	0.995	0.005
Y57.8 Other drugs and medicaments	0.005	0.995	0.000
C10.9 Oropharynx, unspecified	0.000	0.995	0.005
M89.95 Disorder of bone, unspecified (Pelvic region and thigh)	0.005	0.995	0.000
Y57.9 Drug or medicament, unspecified	0.005	0.995	0.000
C07 Malignant neoplasm of parotid gland	0.000	0.995	0.005
L97 Ulcer of lower limb, not elsewhere classified	0.005	0.995	0.000
C10 Malignant neoplasm of oropharynx	0.000	0.995	0.005
C01 Malignant neoplasm of base of tongue	0.000	0.995	0.004
Y57.5 X-ray contrast media	0.004	0.996	0.000
G31.2 Degeneration of nervous system due to alcohol	0.000	0.996	0.004
C25.0 Head of pancreas	0.004	0.996	0.000
G31.1 Senile degeneration of brain, not elsewhere classified	0.000	0.996	0.004
C25 Malignant neoplasm of pancreas	0.004	0.996	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.000	0.996	0.004
C09.9 Tonsil, unspecified	0.000	0.996	0.004
S39.9 Unspecified injury of abdomen, lower back and pelvis	0.004	0.996	0.000
C09 Malignant neoplasm of tonsil	0.000	0.996	0.004
C25.1 Body of pancreas	0.004	0.996	0.000
C25.4 Endocrine pancreas	0.004	0.996	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.004	0.996	0.000
M06 Other rheumatoid arthritis	0.004	0.996	0.000
F41.0 Panic disorder [episodic paroxysmal anxiety]	0.004	0.996	0.000
C25.9 Pancreas, unspecified	0.004	0.996	0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.000	0.996	0.004
E06.3 Autoimmune thyroiditis	0.004	0.996	0.000
G25 Other extrapyramidal and movement disorders	0.004	0.996	0.000
G25.9 Extrapyramidal and movement disorder, unspecified	0.004	0.996	0.000
C25.2 Tail of pancreas	0.004	0.996	0.000
G25.0 Essential tremor	0.004	0.996	0.000
C25.8 Overlapping lesion of pancreas	0.004	0.996	0.000
G25.2 Other specified forms of tremor	0.004	0.996	0.000
C06 Malignant neoplasm of other and unspecified parts of mouth	0.000	0.996	0.004
C05 Malignant neoplasm of palate	0.000	0.996	0.003
C25.3 Pancreatic duct	0.003	0.996	0.000
C10.8 Overlapping lesion of oropharynx	0.000	0.996	0.003
C10.4 Branchial cleft	0.000	0.996	0.003
C10.3 Posterior wall of oropharynx	0.000	0.996	0.003
C10.2 Lateral wall of oropharynx	0.000	0.996	0.003
C10.1 Anterior surface of epiglottis	0.000	0.996	0.003
C10.0 Vallecula	0.000	0.996	0.003
N48.4 Impotence of organic origin	0.004	0.996	0.000
W06.0 Home	0.004	0.996	0.000
E14 Unspecified diabetes mellitus	0.004	0.996	0.000
C25.7 Other parts of pancreas	0.003	0.997	0.000
C08 Malignant neoplasm of other and unspecified major salivary glands	0.000	0.997	0.003
G25.8 Other specified extrapyramidal and movement disorders	0.003	0.997	0.000
Y43.1 Antineoplastic antimetabolites	0.003	0.997	0.001
C03 Malignant neoplasm of gum	0.000	0.997	0.003
C13 Malignant neoplasm of hypopharynx	0.000	0.997	0.003
C09.8 Overlapping lesion of tonsil	0.000	0.997	0.003
C09.1 Tonsillar pillar (anterior) (posterior)	0.000	0.997	0.003
C09.0 Tonsillar fossa	0.000	0.997	0.003
C14.0 Pharynx, unspecified	0.000	0.997	0.003
E14.2 Withrenal complications	0.003	0.997	0.000
G25.1 Drug-induced tremor	0.003	0.997	0.000
F41 Other anxiety disorders	0.003	0.997	0.000
Y44.2 Anticoagulants	0.002	0.997	0.001
M06.8 Other specified rheumatoid arthritis	0.003	0.997	0.000
M06.2 Rheumatoid bursitis	0.003	0.997	0.000
M06.1 Adult-onset Still's disease	0.003	0.997	0.000
O02.1 Missed abortion	0.003	0.997	0.000
C00 Malignant neoplasm of lip	0.000	0.997	0.003
M48.07 Spinal stenosis (Lumbosacral region)	0.003	0.997	0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.003	0.997	0.000
C12 Malignant neoplasm of pyriform sinus	0.000	0.997	0.003
Z50.9 Care involving use of rehabilitation procedure, unspecified	0.000	0.997	0.003
Y52 Agents primarily affecting the cardiovascular system	0.003	0.997	0.000
S82.21 Fracture of shaft of tibia (open)	0.000	0.997	0.003
C05.9 Palate, unspecified	0.000	0.997	0.003
F41.8 Other specified anxiety disorders	0.003	0.997	0.000
C14.8 Overlapping lesion of lip, oral cavity and pharynx	0.000	0.997	0.003
C14.2 Waldeyer's ring	0.000	0.997	0.003
F41.3 Other mixed anxiety disorders	0.003	0.997	0.000
G45.4 Transient global amnesia	0.000	0.997	0.003
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.003	0.997	0.000
E14.8 With unspecified complications	0.003	0.997	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.000	0.997	0.003
C06.9 Mouth, unspecified	0.000	0.997	0.003
G25.6 Drug-induced tics and other tics of organic origin	0.003	0.997	0.000
G25.5 Other chorea	0.003	0.997	0.000
G25.4 Drug-induced chorea	0.003	0.997	0.000
E14.6 With other specified complications	0.003	0.997	0.000
C11 Malignant neoplasm of nasopharynx	0.000	0.997	0.002
E10.3 With ophthalmic complications	0.003	0.997	0.000
F41.2 Mixed anxiety and depressive disorder	0.003	0.997	0.000
I86.4 Gastric varices	0.003	0.997	0.000
E14.5 With peripheral circulatory complications	0.003	0.997	0.000
Y42.5 Other oestrogens and progestogens	0.003	0.997	0.000
C06.0 Cheek mucosa	0.000	0.997	0.003
C06.8 Overlapping lesion of other and unspecified parts of mouth	0.000	0.997	0.003
C06.2 Retromolar area	0.000	0.997	0.003
C06.1 Vestibule of mouth	0.000	0.997	0.003
C05.8 Overlapping lesion of palate	0.000	0.997	0.003
C05.2 Uvula	0.000	0.997	0.003
C05.0 Hard palate	0.000	0.997	0.003
F40.2 Specific (isolated) phobias	0.003	0.997	0.000
C04 Malignant neoplasm of floor of mouth	0.000	0.997	0.003
C08.9 Major salivary gland, unspecified	0.000	0.997	0.003
E13.3 With ophthalmic complications	0.003	0.997	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.997	0.003
E14.7 With multiple complications	0.003	0.997	0.000
E14.0 With coma	0.003	0.997	0.000
C05.1 Soft palate	0.000	0.997	0.003
C08.8 Overlapping lesion of major salivary glands	0.000	0.997	0.003
C08.1 Sublingual gland	0.000	0.997	0.003
C08.0 Submandibular gland	0.000	0.997	0.003
C03.9 Gum, unspecified	0.000	0.997	0.003
C03.1 Lower gum	0.000	0.997	0.003
C03.0 Upper gum	0.000	0.997	0.003
C13.8 Overlapping lesion of hypopharynx	0.000	0.997	0.003
C13.2 Posterior wall of hypopharynx	0.000	0.997	0.003
C13.1 Aryepiglottic fold, hypopharyngeal aspect	0.000	0.997	0.003
C13.0 Postcricoid region	0.000	0.997	0.003
C13.9 Hypopharynx, unspecified	0.000	0.997	0.003
E10 Insulin-dependent diabetes mellitus	0.003	0.997	0.000
E10.4 With neurological complications	0.003	0.997	0.000
E10.8 With unspecified complications	0.003	0.997	0.000
F41.1 Generalised anxiety disorder	0.003	0.997	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.997	0.000
W06 Fall involving bed	0.003	0.997	0.000
C00.0 External upper lip	0.000	0.997	0.002
I86.1 Scrotal varices	0.003	0.997	0.000
M06.4 Inflammatory polyarthropathy	0.002	0.997	0.000
E13 Other specified diabetes mellitus	0.003	0.997	0.000
M06.19 Adult-onset Still's disease (Site unspecified)	0.002	0.997	0.000
M06.18 Adult-onset Still's disease (Other)	0.002	0.997	0.000
M06.17 Adult-onset Still's disease (Ankle and foot)	0.002	0.997	0.000
M06.16 Adult-onset Still's disease (Lower leg)	0.002	0.997	0.000
M06.15 Adult-onset Still's disease (Pelvic region and thigh)	0.002	0.997	0.000
M06.14 Adult-onset Still's disease (Hand)	0.002	0.997	0.000
M06.13 Adult-onset Still's disease (Forearm)	0.002	0.997	0.000
M06.12 Adult-onset Still's disease (Upper arm)	0.002	0.997	0.000
M06.11 Adult-onset Still's disease (Shoulder region)	0.002	0.997	0.000
M06.10 Adult-onset Still's disease (Multiple sites)	0.002	0.997	0.000
M06.29 Rheumatoid bursitis (Site unspecified)	0.002	0.997	0.000
M06.28 Rheumatoid bursitis (Other)	0.002	0.997	0.000
M06.27 Rheumatoid bursitis (Ankle and foot)	0.002	0.997	0.000
M06.26 Rheumatoid bursitis (Lower leg)	0.002	0.997	0.000
M06.25 Rheumatoid bursitis (Pelvic region and thigh)	0.002	0.997	0.000
M06.24 Rheumatoid bursitis (Hand)	0.002	0.997	0.000
M06.23 Rheumatoid bursitis (Forearm)	0.002	0.997	0.000
M06.22 Rheumatoid bursitis (Upper arm)	0.002	0.997	0.000
M06.21 Rheumatoid bursitis (Shoulder region)	0.002	0.997	0.000
M06.20 Rheumatoid bursitis (Multiple sites)	0.002	0.997	0.000
M06.89 Other specified rheumatoid arthritis (Site unspecified)	0.002	0.997	0.000
M06.88 Other specified rheumatoid arthritis (Other)	0.002	0.997	0.000
M06.87 Other specified rheumatoid arthritis (Ankle and foot)	0.002	0.997	0.000
M06.86 Other specified rheumatoid arthritis (Lower leg)	0.002	0.997	0.000
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)	0.002	0.997	0.000
M06.84 Other specified rheumatoid arthritis (Hand)	0.002	0.997	0.000
M06.83 Other specified rheumatoid arthritis (Forearm)	0.002	0.997	0.000
M06.82 Other specified rheumatoid arthritis (Upper arm)	0.002	0.997	0.000
M06.81 Other specified rheumatoid arthritis (Shoulder region)	0.002	0.997	0.000
M06.80 Other specified rheumatoid arthritis (Multiple sites)	0.002	0.997	0.000
C00.8 Overlapping lesion of lip	0.000	0.997	0.002
C00.6 Commissure of lip	0.000	0.997	0.002
C00.5 Lip, unspecified, inner aspect	0.000	0.997	0.002
C00.4 Lower lip, inner aspect	0.000	0.997	0.002
C00.3 Upper lip, inner aspect	0.000	0.997	0.002
C00.2 External lip, unspecified	0.000	0.997	0.002
E10.5 With peripheral circulatory complications	0.002	0.997	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.997	0.000
Y52.7 Peripheral vasodilators	0.002	0.997	0.000
S82.4 Fracture of fibula alone	0.002	0.998	0.000
C00.1 External lower lip	0.000	0.998	0.002
E14.4 With neurological complications	0.002	0.998	0.000
Y43.3 Other antineoplastic drugs	0.002	0.998	0.000
C02.8 Overlapping lesion of tongue	0.000	0.998	0.002
C02.4 Lingual tonsil	0.000	0.998	0.002
C02.3 Anterior two-thirds of tongue, part unspecified	0.000	0.998	0.002
C02.2 Ventral surface of tongue	0.000	0.998	0.002
C02.0 Dorsal surface of tongue	0.000	0.998	0.002
G25.3 Myoclonus	0.002	0.998	0.000
M89.9 Disorder of bone, unspecified	0.002	0.998	0.000
C02.9 Tongue, unspecified	0.000	0.998	0.002
C11.8 Overlapping lesion of nasopharynx	0.000	0.998	0.002
C11.3 Anterior wall of nasopharynx	0.000	0.998	0.002
C11.2 Lateral wall of nasopharynx	0.000	0.998	0.002
C11.1 Posterior wall of nasopharynx	0.000	0.998	0.002
C11.0 Superior wall of nasopharynx	0.000	0.998	0.002
M06.3 Rheumatoid nodule	0.002	0.998	0.000
E14.1 With ketoacidosis	0.002	0.998	0.000
E10-E14 Diabetes mellitus	0.002	0.998	0.000
C04.8 Overlapping lesion of floor of mouth	0.000	0.998	0.002
C04.1 Lateral floor of mouth	0.000	0.998	0.002
W18.5 Trade and service area	0.002	0.998	0.000
I60.9 Subarachnoid haemorrhage, unspecified	0.002	0.998	0.000
I47.2 Ventricular tachycardia	0.002	0.998	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
F40 Phobic anxiety disorders	0.002	0.998	0.000
Y00 Assault by blunt object	0.002	0.998	0.000
E10.7 With multiple complications	0.002	0.998	0.000
E13.9 Without complications	0.002	0.998	0.000
C00.9 Lip, unspecified	0.000	0.998	0.002
G24.5 Blepharospasm	0.002	0.998	0.000
Y00.0 Home	0.002	0.998	0.000
C84.0 Mycosis fungoides	0.002	0.998	0.000
E10.2 With renal complications	0.002	0.998	0.000
W06.2 School, other institution and public administrative area	0.002	0.998	0.000
W06.8 Other specified place	0.002	0.998	0.000
W06.7 Farm	0.002	0.998	0.000
W06.6 Industrial and construction area	0.002	0.998	0.000
W06.5 Trade and service area	0.002	0.998	0.000
W06.4 Street and highway	0.002	0.998	0.000
W06.3 Sports and athletics area	0.002	0.998	0.000
W06.1 Residential institution	0.002	0.998	0.000
M06.48 Inflammatory polyarthropathy (Other)	0.002	0.998	0.000
M06.47 Inflammatory polyarthropathy (Ankle and foot)	0.002	0.998	0.000
M06.46 Inflammatory polyarthropathy (Lower leg)	0.002	0.998	0.000
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)	0.002	0.998	0.000
M06.44 Inflammatory polyarthropathy (Hand)	0.002	0.998	0.000
M06.43 Inflammatory polyarthropathy (Forearm)	0.002	0.998	0.000
M06.42 Inflammatory polyarthropathy (Upper arm)	0.002	0.998	0.000
M06.41 Inflammatory polyarthropathy (Shoulder region)	0.002	0.998	0.000
L89.2 Stage III decubitus ulcer	0.000	0.998	0.002
Y00.9 Unspecified place	0.002	0.998	0.000
W75-W84 Other accidental threats to breathing	0.002	0.998	0.000
W20-W49 Exposure to inanimate mechanical forces	0.002	0.998	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.002	0.998	0.000
E13.8 With unspecified complications	0.002	0.998	0.000
E13.7 With multiple complications	0.002	0.998	0.000
E13.6 With other specified complications	0.002	0.998	0.000
E13.5 With peripheral circulatory complications	0.002	0.998	0.000
E13.4 With neurological complications	0.002	0.998	0.000
E13.2 With renal complications	0.002	0.998	0.000
E13.1 With ketoacidosis	0.002	0.998	0.000
E13.0 With coma	0.002	0.998	0.000
W78 Inhalation of gastric contents	0.002	0.998	0.000
Y00-Y09 Assault	0.002	0.998	0.000
T11.0 Superficial injury of upper limb, level unspecified	0.000	0.998	0.002
W78.2 School, other institution and public administrative area	0.002	0.998	0.000
W18 Other fall on same level	0.002	0.998	0.000
E10.0 With coma	0.002	0.998	0.000
W06.9 Unspecified place	0.002	0.998	0.000
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
E06 Thyroiditis	0.002	0.998	0.000
Chapter XX External causes of morbidity and mortality	0.002	0.998	0.000
Y81.2 Prosthetic and other implants, materials and accessory devices	0.002	0.998	0.000
S82.41 Fracture of fibula alone (open)	0.002	0.998	0.000
C04.9 Floor of mouth, unspecified	0.000	0.998	0.002
C11.9 Nasopharynx, unspecified	0.001	0.998	0.001
C18.0 Caecum	0.002	0.998	0.000
F40.9 Phobic anxiety disorder, unspecified	0.002	0.998	0.000
N30.3 Trigonitis	0.002	0.998	0.000
T42.4 Benzodiazepines	0.000	0.998	0.002
Z88.1 Personal history of allergy to other antibiotic agents	0.002	0.998	0.000
N41.9 Inflammatory disease of prostate, unspecified	0.000	0.998	0.002
W05 Fall involving wheelchair	0.002	0.998	0.000
Y60-Y69 Misadventures to patients during surgical and medical care	0.002	0.998	0.000
M89.99 Disorder of bone, unspecified (Site unspecified)	0.002	0.998	0.000
M89.96 Disorder of bone, unspecified (Lower leg)	0.002	0.998	0.000
M89.94 Disorder of bone, unspecified (Hand)	0.002	0.998	0.000
M89.93 Disorder of bone, unspecified (Forearm)	0.002	0.998	0.000
M89.92 Disorder of bone, unspecified (Upper arm)	0.002	0.998	0.000
M89.91 Disorder of bone, unspecified (Shoulder region)	0.002	0.998	0.000
M89.90 Disorder of bone, unspecified (Multiple sites)	0.002	0.998	0.000
C04.0 Anterior floor of mouth	0.000	0.998	0.002
W28 Contact with powered lawn mower	0.002	0.998	0.000
E06.9 Thyroiditis, unspecified	0.002	0.998	0.000
E10.6 With other specified complications	0.002	0.998	0.000
G23.1 Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]	0.002	0.998	0.000
W27 Contact with nonpowered hand tool	0.002	0.998	0.000
M10.06 Idiopathic gout (Lower leg)	0.002	0.998	0.000
M10.0 Idiopathic gout	0.002	0.998	0.000
W34 Discharge from other and unspecified firearms	0.002	0.998	0.000
M06.39 Rheumatoid nodule (Site unspecified)	0.002	0.998	0.000
M06.38 Rheumatoid nodule (Other)	0.002	0.998	0.000
M06.36 Rheumatoid nodule (Lower leg)	0.002	0.998	0.000
M06.35 Rheumatoid nodule (Pelvic region and thigh)	0.002	0.998	0.000
M06.33 Rheumatoid nodule (Forearm)	0.002	0.998	0.000
M06.31 Rheumatoid nodule (Shoulder region)	0.002	0.998	0.000
M06.30 Rheumatoid nodule (Multiple sites)	0.002	0.998	0.000
M06.40 Inflammatory polyarthropathy (Multiple sites)	0.002	0.998	0.000
M10.09 Idiopathic gout (Site unspecified)	0.002	0.998	0.000
M10.00 Idiopathic gout (Multiple sites)	0.002	0.998	0.000
Y81 General- and plastic-surgery devices associated with adverse incidents	0.002	0.998	0.000
W00-W19 Falls	0.002	0.998	0.000
Z35.5 Supervision of elderly primigravida	0.000	0.998	0.002
E12 Malnutrition-related diabetes mellitus	0.002	0.998	0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.002	0.998	0.000
M89.98 Disorder of bone, unspecified (Other)	0.002	0.998	0.000
F40.8 Other phobic anxiety disorders	0.002	0.998	0.000
W50.4 Street and highway	0.002	0.998	0.000
G95.1 Vascular myelopathies	0.000	0.998	0.002
W05.2 School, other institution and public administrative area	0.002	0.998	0.000
W28.9 Unspecified place	0.002	0.998	0.000
I60 Subarachnoid haemorrhage	0.002	0.998	0.000
I86 Varicose veins of other sites	0.002	0.998	0.000
W26 Contact with knife, sword or dagger	0.002	0.998	0.000
W79 Inhalation and ingestion of food causing obstruction of respiratory tract	0.002	0.998	0.000
X10-X19 Contact with heat and hot substances	0.002	0.998	0.000
F40.1 Social phobias	0.002	0.998	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations